Dare Bioscience
DARE
36 hedge funds and large institutions have $3.35M invested in Dare Bioscience in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
64% more capital invested
Capital invested by funds: $2.04M → $3.35M (+$1.31M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 35 → 36 (+1)
0.02% more ownership
Funds ownership: 0.56% → 0.58% (+0.02%)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$65.8K |
| 2 |
Renaissance Technologies
New York
|
+$17.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$13.6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$11.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$14.7K |
| 2 |
VH
Visionary Horizons
Knoxville,
Tennessee
|
-$11.5K |
| 3 |
ZIG
Zuckerman Investment Group
Chicago,
Illinois
|
-$7.13K |
| 4 |
JP Morgan Chase
New York
|
-$4.92K |
| 5 |
VF
Virtu Financial
New York
|
-$4K |
DARE Hedge Fund Activity: Q1 2024 in Review
36 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2024, worth a combined $3.35M — up 64% from $2.04M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DARE positions and 6 closed out — a net gain of 1 holder — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $65.8K. The largest seller was HighTower Advisors, cutting an estimated $14.7K.
- 36 institutional investors held Dare Bioscience (DARE) as of Q1 2024, up from 35 in Q4 2023.
- Funds reported $3.35M of Dare Bioscience stock for Q1 2024, up 64% quarter-over-quarter.
- 7 funds opened new Dare Bioscience positions in Q1 2024 and 6 closed out, a net change of +1 holder.
- The largest Dare Bioscience buyer in Q1 2024 was Citadel Advisors, an estimated $65.8K added.
- The largest Dare Bioscience seller in Q1 2024 was HighTower Advisors, an estimated $14.7K sold.
Based on aggregated 13F filings for Q1 2024.